Oppenheimer Remains Sidelined Following Endo Int'l's (ENDP) New CEO Appointment

Piper Jaffray Reiterates Neutral as Endo Int'l (ENDP) Announces Paul Campanelli as New CEO

September 26, 2016 8:26 AM EDT

Piper Jaffray reiterated a Neutral rating and $19.00 price target on Endo International plc (NASDAQ: ENDP) following the company's announcement appointment of Paul Campanelli as CEO effective immediately. Mr. Campanelli was responsible for the 2014 acquisition of JHP Pharma, which gave Par a sizable generic injectibles business and more importantly gave the... More

Unusual 11 Mid-Day Movers 9/23: (IMPV) (BLRX) (TWTR) Higher; (ENPH) (APPS) (RAVE) Lower

September 23, 2016 12:52 PM EDT

Enphase Energy Inc. (Nasdaq: ENPH) 25.8% LOWER; announced the pricing of the previously announced underwritten public offering of 13,000,000 shares of its common stock, offered at a price to the public of $1.20 per share. Certain directors, officers, and employees of Enphase are expected to purchase approximately $1.2 million of common stock in this offering.

Imperva (NYSE: IMPV) 22.2% HIGHER; is said to draw takeover interest from Cisco Systems, IBM, according to a Bloomberg report.

BioLineRx Ltd. (Nasdaq: BLRX)... More

Leerink Not Surprised by CEO Change at Endo Int'l (ENDP); Affirms at 'Market Perform'

September 23, 2016 8:48 AM EDT

Leerink affirms Endo Int'l (Nasdaq: ENDP) at Market Perform with a price target of $22 following news of a key executive change.

The firm commented today, This morning ENDP announced that Rajiv De Silva will step down as CEO and be replaced... More

Janney Montgomery Scott Upgrades BioDelivery Sciences International (BDSI) to Buy

September 23, 2016 7:25 AM EDT

Janney Montgomery Scott upgraded BioDelivery Sciences International (NASDAQ: BDSI) from Neutral to Buy with a price target of $4.00 as Belbuca will be added as the preferred brand over Butrant on United Healthcare Formulary.

Analyst Ken Trbovich commented, "Endo International plc (NASDAQ:... More

Wall Street falls as energy lags; shares post gains on week

September 23, 2016 7:22 AM EDT

By Lewis Krauskopf

(Reuters) - Wall Street retreated on Friday as lower oil prices weighed on energy shares and Facebook and Apple declined, but major indexes still posted gains for the week.

Energy was the worst-performing major S&P sector, dropping 1.3 percent. Oil prices tumbled 4 percent on signs Saudi Arabia and Iran were making little progress on a bilateral agreement ahead of talks by crude exporters aimed at freezing production.

Facebook (NASDAQ: FB) shares fell 1.6 percent and were one of the biggest drags on the S&P 500. The Wall Street Journal... More

Endo Int'l (ENDP) CEO De Silva Resigns; New CEO Appointed; Guidance Reaffirmed

September 23, 2016 7:03 AM EDT

Endo International plc (Nasdaq: ENDP) announced that its Board of Directors has named Paul V. Campanelli President and Chief Executive Officer, effective immediately. Mr. Campanelli currently serves as President of Endo's Generic and OTC drugs business, Par Pharmaceutical, which accounts for approximately 60 percent of Endo's total revenues through the first half of 2016. Campanelli, who will also join Endo's Board of Directors, succeeds Rajiv De Silva, who has stepped down as President, CEO and a member of the Board.

Campanelli, 54, joined Endo in 2015 following Endo's acquisition of Par Pharmaceutical, where he had served as... More